Management is re-underwriting a specific asset or business at a value far above its cost, using fresh third-party marks
The model's full reasoning — Q3 2018 call → NOWe need to determine if management puts a concrete, externally-derived value on something the company already owns or controls, and conveys that this value is far above what the company paid, carries it at, or what current results would imply. Look for specific asset being valued and an outside reference point. In the transcript, management discusses the SurVeil Drug-Coated Balloon agreement with Abbott. They received $25 million upfront license fee. They recognize revenue over time. They mention deferred revenue of $10.3 million. But that's accounting, not a market valuation. They also discuss the Embolitech acquisition - they paid $4.5 million for IP R&D. They mention the thrombectomy market is $400 million. But they don't put a value on the technology itself. They discuss products like Telemark microcatheter, .014 balloon, etc. They mention clinical evaluations and interested parties, but no specific valuation. They mention the Abbott deal: "we will supply the SurVeil Drug-Coated Balloon to Abbott and collaborate... Abbott also received options...". They don't put a value on the SurVeil asset itself beyond the revenue recognition. They mention "we are updating our expectations for fiscal 2018 revenue" etc. That's operating results. No specific asset is valued against an external reference point. The only external reference is the Abbott deal itself, but they don't say "this deal implies our SurVeil is worth X" or anything like that. They mention "the $7.9 million acquired in-process research and development charge" - that's accounting. They mention "we realized $600,000 of foreign exchange gain on a euro denominated contingent consideration obligation" - that's routine. No clear instance of management pricing a specific holding against an outside reference to show hidden value. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
TTI · Q1 2024 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies a specific asset: its holdings in Standard Lithium and Kodiak Gas Services (marketable securities worth slightly over $13 million, with total marketable securities around $30 million). It grounds the value in an external reference—the recent Kodiak acquisition of CSI Compressco, which made the stake “very favorable to TETRA,” plus Kodiak’s $2.5 billion market cap and strong trading volumes that allow quick, low-pressure monetization.
GPRE · Q4 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Todd Becker explicitly identifies the company's ethanol plants as the specific asset being valued. He states that a high-quality plant trades in the private market at $1.80–$2.00 per gallon (or $2–$2.50 to build from scratch), while the company's overall market cap and net debt imply a lower value for its ~950 million gallon capacity.
AFL · Q2 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies the specific equity stake in Varagon Capital (a minority interest they already held) and grounds its value in the external transaction where Man Group is acquiring Varagon.